(NewsDirect)
ValeoPharma Inc. (TSX:VPH, OTCQB:VPHIF) CEO Steve Saviuk joinedProactive's Stephen Gunnion to discuss the company's strongposition on the Globe and Mail's Report on Business annual list ofCanada’s top-growing companies.
The company placed 151 out of 425 companies, with athree-year growth rate of 322%.
Saviuk explained that the rankings are calculatedon revenue growth, and the exponential growth in the company'sEnerzair asthma therapy helped it secure its position. Despitelaunching less than two years ago, he said Enerzair already rankssecond in Canada's inhaled asthma drug market, accounting forapproximately one out of every five prescriptions.
Given the currenttrajectory, Saviuk said the company may rank even higher in2024.
The Reporton Business magazine launched Canada’s Top Growing Companies rankingin 2019 and companies have to complete an in-depth application processand fulfill certain requirements in order to be recognized.
Valeo Pharma is a fast-growing Canadianpharmaceutical company dedicated to the commercialization ofinnovative prescription products in Canada with a focus onRespiratory/Allergy, Ophthalmology and Hospital SpecialtyProducts.
Contact Details
Proactive
+1604-688-8158
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.